Cigna Group $CI Shares Bought by Hanson & Doremus Investment Management

Hanson & Doremus Investment Management grew its holdings in shares of Cigna Group (NYSE:CIFree Report) by 88.3% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 1,578 shares of the health services provider’s stock after purchasing an additional 740 shares during the period. Hanson & Doremus Investment Management’s holdings in Cigna Group were worth $522,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also modified their holdings of the company. Flaharty Asset Management LLC acquired a new stake in shares of Cigna Group in the 1st quarter worth approximately $28,000. 1248 Management LLC acquired a new stake in shares of Cigna Group in the 1st quarter worth approximately $29,000. Activest Wealth Management grew its holdings in shares of Cigna Group by 360.0% in the 1st quarter. Activest Wealth Management now owns 92 shares of the health services provider’s stock worth $30,000 after acquiring an additional 72 shares during the period. Retirement Wealth Solutions LLC grew its holdings in shares of Cigna Group by 74.1% in the 2nd quarter. Retirement Wealth Solutions LLC now owns 101 shares of the health services provider’s stock worth $33,000 after acquiring an additional 43 shares during the period. Finally, Saudi Central Bank acquired a new stake in shares of Cigna Group in the 1st quarter worth approximately $36,000. Institutional investors and hedge funds own 86.99% of the company’s stock.

Insider Activity

In other news, insider Nicole S. Jones sold 28,526 shares of the firm’s stock in a transaction on Friday, August 15th. The stock was sold at an average price of $300.00, for a total transaction of $8,557,800.00. Following the sale, the insider owned 25,648 shares in the company, valued at $7,694,400. This trade represents a 52.66% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 0.70% of the stock is owned by company insiders.

Cigna Group Price Performance

CI stock opened at $286.04 on Monday. Cigna Group has a 52-week low of $256.89 and a 52-week high of $358.88. The stock’s fifty day simple moving average is $292.71 and its 200-day simple moving average is $310.49. The company has a quick ratio of 0.71, a current ratio of 0.71 and a debt-to-equity ratio of 0.65. The stock has a market capitalization of $76.35 billion, a price-to-earnings ratio of 15.61, a price-to-earnings-growth ratio of 0.84 and a beta of 0.48.

Cigna Group (NYSE:CIGet Free Report) last posted its quarterly earnings data on Thursday, July 31st. The health services provider reported $7.20 earnings per share (EPS) for the quarter, topping the consensus estimate of $7.15 by $0.05. Cigna Group had a return on equity of 18.80% and a net margin of 1.92%.The business had revenue of $67.13 billion for the quarter, compared to analysts’ expectations of $62.61 billion. During the same quarter last year, the firm earned $6.72 earnings per share. The business’s revenue was up 11.0% on a year-over-year basis. Cigna Group has set its FY 2025 guidance at 29.600- EPS. Equities research analysts expect that Cigna Group will post 29.77 EPS for the current year.

Cigna Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Thursday, September 18th. Stockholders of record on Thursday, September 4th were issued a dividend of $1.51 per share. The ex-dividend date was Thursday, September 4th. This represents a $6.04 annualized dividend and a dividend yield of 2.1%. Cigna Group’s dividend payout ratio (DPR) is 32.97%.

Wall Street Analyst Weigh In

A number of equities research analysts recently weighed in on the company. Cantor Fitzgerald restated an “overweight” rating and issued a $365.00 price target on shares of Cigna Group in a report on Tuesday, August 26th. Wells Fargo & Company lowered their target price on Cigna Group from $341.00 to $340.00 and set an “equal weight” rating on the stock in a report on Thursday, August 14th. TD Cowen upgraded Cigna Group to a “strong-buy” rating in a report on Monday, June 23rd. Deutsche Bank Aktiengesellschaft set a $415.00 target price on Cigna Group and gave the company a “buy” rating in a report on Tuesday, August 5th. Finally, Royal Bank Of Canada reiterated an “outperform” rating and set a $371.00 target price on shares of Cigna Group in a report on Thursday, June 26th. Two investment analysts have rated the stock with a Strong Buy rating, fourteen have assigned a Buy rating and two have issued a Hold rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Buy” and a consensus price target of $371.81.

View Our Latest Stock Analysis on CI

About Cigna Group

(Free Report)

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.

Read More

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Group (NYSE:CIFree Report).

Institutional Ownership by Quarter for Cigna Group (NYSE:CI)

Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.